168 related articles for article (PubMed ID: 19096745)
21. The position of strontium ranelate in today's management of osteoporosis.
Reginster JY; Brandi ML; Cannata-Andía J; Cooper C; Cortet B; Feron JM; Genant H; Palacios S; Ringe JD; Rizzoli R
Osteoporos Int; 2015 Jun; 26(6):1667-71. PubMed ID: 25868510
[TBL] [Abstract][Full Text] [Related]
22. A comparative study of Sr-incorporated mesoporous bioactive glass scaffolds for regeneration of osteopenic bone defects.
Wei L; Ke J; Prasadam I; Miron RJ; Lin S; Xiao Y; Chang J; Wu C; Zhang Y
Osteoporos Int; 2014 Aug; 25(8):2089-96. PubMed ID: 24807629
[TBL] [Abstract][Full Text] [Related]
23. Strontium Ranelate and Strontium Chloride Supplementation Influence on Bone Microarchitecture and Bone Turnover Markers-A Preliminary Study.
Turżańska K; Tomczyk-Warunek A; Dobrzyński M; Jarzębski M; Patryn R; Niezbecka-Zając J; Wojciechowska M; Mela A; Zarębska-Mróz A
Nutrients; 2023 Dec; 16(1):. PubMed ID: 38201922
[TBL] [Abstract][Full Text] [Related]
24. [Suitability of strontium ranelate in a health care management area after drug surveillance alerts].
Cantudo-Cuenca MR; Calvo-Cidoncha E; Robustillo-Cortés MA; Saborido-Cansino MC; Gómez-Estrella G; Sánchez-Pedrosa A
Aten Primaria; 2016 Jan; 48(1):49-53. PubMed ID: 25900199
[TBL] [Abstract][Full Text] [Related]
25. Clinically meaningful effect of strontium ranelate on symptoms in knee osteoarthritis: a responder analysis.
Bruyère O; Reginster JY; Bellamy N; Chapurlat R; Richette P; Cooper C;
Rheumatology (Oxford); 2014 Aug; 53(8):1457-64. PubMed ID: 24667161
[TBL] [Abstract][Full Text] [Related]
26. Nationwide registry-based analysis of cardiovascular risk factors and adverse outcomes in patients treated with strontium ranelate.
Abrahamsen B; Grove EL; Vestergaard P
Osteoporos Int; 2014 Feb; 25(2):757-62. PubMed ID: 24322475
[TBL] [Abstract][Full Text] [Related]
27. Cardiac concerns associated with strontium ranelate.
Reginster JY
Expert Opin Drug Saf; 2014 Sep; 13(9):1209-13. PubMed ID: 25020233
[TBL] [Abstract][Full Text] [Related]
28. Systemic treatment with strontium ranelate accelerates the filling of a bone defect and improves the material level properties of the healing bone.
Zacchetti G; Dayer R; Rizzoli R; Ammann P
Biomed Res Int; 2014; 2014():549785. PubMed ID: 25243150
[TBL] [Abstract][Full Text] [Related]
29. Strontium enhances osseointegration of calcium phosphate cement: a histomorphometric pilot study in ovariectomized rats.
Baier M; Staudt P; Klein R; Sommer U; Wenz R; Grafe I; Meeder PJ; Nawroth PP; Kasperk C
J Orthop Surg Res; 2013 Jun; 8():16. PubMed ID: 23758869
[TBL] [Abstract][Full Text] [Related]
30. Strontium ranelate for the treatment of osteoporosis.
Fogelman I; Blake GM
BMJ; 2005 Jun; 330(7505):1400-1. PubMed ID: 15961793
[No Abstract] [Full Text] [Related]
31. Strontium ranelate enriched Ruminococcus albus in the gut microbiome of Sprague-Dawley rats with postmenopausal osteoporosis.
Xiao X; Cui Y; Lu H; Wang J; Yang J; Liu L; Liu Z; Peng X; Cao H; Liu X; Wei X
BMC Microbiol; 2023 Nov; 23(1):365. PubMed ID: 38008735
[TBL] [Abstract][Full Text] [Related]
32. Osteogenic effect of magnesium oxychloride cement modified with phytic acid and loaded with strontium ranelate.
Ma T; Guan Y; Feng J; Yang Y; Chen J; Guo W; Liao J; Zhang Y
Biomater Res; 2023 Dec; 27(1):128. PubMed ID: 38072982
[TBL] [Abstract][Full Text] [Related]
33. A physiologically based pharmacokinetic model for strontium exposure in rat.
Pertinez H; Chenel M; Aarons L
Pharm Res; 2013 Jun; 30(6):1536-52. PubMed ID: 23543304
[TBL] [Abstract][Full Text] [Related]
34. Effectiveness of Strontium Ranelate in the Treatment of Rat Model of Legg-Calve-Perthes Disease.
Chen YP; Tan A; Ho WP; Chuang TY; Chen WC; Chen CH
Indian J Orthop; 2018; 52(4):380-386. PubMed ID: 30078896
[TBL] [Abstract][Full Text] [Related]
35. Strontium-doped calcium phosphate and hydroxyapatite granules promote different inflammatory and bone remodelling responses in normal and ovariectomised rats.
Cardemil C; Elgali I; Xia W; Emanuelsson L; Norlindh B; Omar O; Thomsen P
PLoS One; 2013; 8(12):e84932. PubMed ID: 24376855
[TBL] [Abstract][Full Text] [Related]
36. Role of Calcitonin and Strontium Ranelate in Osteoporosis.
Ghani A; Arfee S
Indian J Orthop; 2023 Dec; 57(Suppl 1):115-119. PubMed ID: 38107820
[TBL] [Abstract][Full Text] [Related]
37. Therapeutic advantages of treatment of high-dose curcumin in the ovariectomized rat.
Cho DC; Jung HS; Kim KT; Jeon Y; Sung JK; Hwang JH
J Korean Neurosurg Soc; 2013 Dec; 54(6):461-6. PubMed ID: 24527187
[TBL] [Abstract][Full Text] [Related]
38. Strontium ranelate as a possible disease-modifying osteoarthritis drug: a systematic review.
Rodrigues TA; Freire AO; Bonfim BF; Cartágenes MSS; Garcia JBS
Braz J Med Biol Res; 2018; 51(8):e7440. PubMed ID: 29924137
[TBL] [Abstract][Full Text] [Related]
39. Bone quality and bone strength: benefits of the bone-forming approach.
Iolascon G; Frizzi L; Di Pietro G; Capaldo A; Luciano F; Gimigliano F
Clin Cases Miner Bone Metab; 2014 Jan; 11(1):20-4. PubMed ID: 25002875
[TBL] [Abstract][Full Text] [Related]
40. Effect of strontium ranelate on pain behavior in an experimental model of osteoarthritis.
Rodrigues TA; Sampaio AJB; Nunes IDP; Cartágenes MSS; Garcia JBS
Braz J Med Biol Res; 2017 Aug; 50(9):e6314. PubMed ID: 28793056
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
